Research Projects to be conducted in Switzerland by members of a Swiss university or research institution. Applicants must be senior researchers responsible for the research project (PI)
You said:
https://www.stiftungmedbiol.novartis.com/guidelines.html Eligibility criteria
ChatGPT said:
Here are the eligibility criteria and requirements from the Novartis Foundation for Medical‑Biological Research Guidelines (based on the official page you linked): stiftungmedbiol.novartis.com+1
The Foundation provides funding (up to CHF 80,000) for:
A) Research Project Grants
✔️ Who can apply
Senior researchers (Principal Investigators) at a Swiss university or research institution.
✔️ Project requirements
Research must be conducted in Switzerland.
Projects must not include any Novartis products.
✔️ Other eligibility rules
Applicants must not have received the same type of grant from the Foundation in the past 5 years.
Maximum project duration for funding is one year
Eligible Countries:
Sponsor Institute/Organizations: Novartis Foundation for Medical- Biological Research
Sponsor Type: Corporate/Non-Profit
Address: Lichtstrasse 35 4002 Basel
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
The dates for submission for the year 2026 are as follows:
January 23rd, 2026
April 17th, 2026
September 11th, 2026
$100,712
CHF 80’000
Affiliation: Novartis Foundation for Medical- Biological Research
Address: Lichtstrasse 35 4002 Basel
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.